Registered Office: Paradigm Shift Consulting Ltd,The Old Mill, 9 Soar Lane,Leicester, LE3 5DE, United Kingdom

Paradigm Shift Consulting Logo

0330 133 0920

Paradigm Shift Consulting Logo
Strengthening your QMS with Quality Risk Management

Strengthening your QMS with Quality Risk Management

Integrating your Quality Risk Management into your QMS Quality Risk Management (QRM) is not just a “nice-to-have” in Good Distribution Practice (GDP), it is a minimum expectation rooted in National law, guidance, and best practice. When applied correctly...
Managing Deviations with Confidence: Essential Insights into GDP Compliance

Managing Deviations with Confidence: Essential Insights into GDP Compliance

Confidence in GDP Deviation Control Ensuring adherence to Good Distribution Practice (GDP) is fundamental to maintaining product quality, legal compliance, and, ultimately, patient safety. When everyday activities on a licensed distribution site become complacent or...
What Are the Main Elements of GDP Guidelines in 2026?

What Are the Main Elements of GDP Guidelines in 2026?

GDP Guidelines: The Main Elements The GDP guidelines (Good Distribution Practice) for medicinal products consist of ten working chapters and two annexes, which cover the following topics: Chapter 1 – Quality Management We start the GDP guidelines with describing...
GN14 Explained: What Pharma Wholesale Distributors Need To Know

GN14 Explained: What Pharma Wholesale Distributors Need To Know

Unlicensed Medicines: Key Guidance Note 14 (GN14) requirements for wholesale distributors When a pharmaceutical wholesaler becomes involved in the sale and supply of unlicensed medicines, often referred to as “Specials”, the scope of their Wholesale Distributors...
Understanding Controlled Drugs Licensing 2026

Understanding Controlled Drugs Licensing 2026

What Wholesalers & Wholesaling Pharmacies of Controlled Drugs Must Know  Holders of a Wholesale Distribution Authorisation (WDA) must abide by a range of complex regulatory landscape. If you supply medicines, in particular, controlled drugs in Schedules 2-5, there...